HESTERBIO Q1 FY27 Guidance vs Delivery (HESTERBIO Management Mirror)

Consolidated EBITDA Reported at INR 228 Million in Jun'26 Qtr, Tracking Against Prior Quarterly Run-Rate Guidance of Around INR 20 Crores

In the Sep'25 Qtr concall, management emphasized protecting margins through process standardization amid a subdued top-line. In the Dec'25 Qtr concall, management stated determination to at least maintain a profitability run rate of around INR 20 crores quarterly EBITDA going forward. For the Jun'26 Qtr, Quarterly Financial Results reported consolidated EBITDA at INR 228 million. Concurrently, the Jun'26 Qtr concall noted standalone gross margins improved to 78% from 69% in the corresponding prior-year quarter, and standalone EBITDA grew by 95% YoY. Additionally, consolidated profitability in the Jun'26 Qtr benefited from an exceptional accounting gain following a Gates Foundation soft loan amendment for Hester Africa, reducing the outstanding loan from USD 12,000,000 to USD 5,000,000 and rendering it interest-free.